Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 21 04:00PM ET
1.60
Dollar change
+0.16
Percentage change
10.97
%
Index- P/E- EPS (ttm)-1.37 Insider Own19.99% Shs Outstand4.44M Perf Week27.84%
Market Cap7.10M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float3.55M Perf Month23.88%
Income-6.01M PEG- EPS next Q- Inst Own8.08% Short Float0.26% Perf Quarter59.80%
Sales0.00M P/S- EPS this Y- Inst Trans-1.54% Short Ratio0.80 Perf Half Y99.75%
Book/sh0.48 P/B3.32 EPS next Y- ROA-117.26% Short Interest0.01M Perf Year-14.55%
Cash/sh0.55 P/C2.93 EPS next 5Y- ROE-140.56% 52W Range0.68 - 2.32 Perf YTD61.41%
Dividend Est.- P/FCF- EPS past 5Y-2.91% ROI-281.68% 52W High-31.12% Beta-
Dividend TTM- Quick Ratio5.53 Sales past 5Y0.00% Gross Margin- 52W Low135.10% ATR (14)0.18
Dividend Ex-Date- Current Ratio5.53 EPS Y/Y TTM-103.80% Oper. Margin0.00% RSI (14)60.15 Volatility17.63% 12.53%
Employees3 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price16.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q-133.79% Payout- Rel Volume2.47 Prev Close1.44
Sales Surprise- EPS Surprise37.50% Sales Q/Q- EarningsApr 01 AMC Avg Volume11.47K Price1.60
SMA2015.93% SMA5012.62% SMA20026.59% Trades Volume28,302 Change10.97%
May-01-24 08:38AM
Apr-17-24 08:42AM
Apr-01-24 09:53PM
04:20PM
Mar-27-24 08:42AM
05:00PM Loading…
Mar-25-24 05:00PM
Mar-21-24 08:41AM
Feb-13-24 08:30AM
Dec-12-23 07:30AM
Oct-13-23 09:00AM
Sep-26-23 08:18AM
Mar-22-23 12:55PM
Apr-26-22 08:15AM
Nov-16-21 09:58AM
Aug-30-21 09:15AM
07:45AM Loading…
Aug-17-21 07:45AM
Jul-23-21 04:21PM
Jul-08-21 11:20AM
Jul-06-21 06:17AM
Jun-23-21 09:35AM
Jun-16-21 09:15AM
Apr-29-21 03:06PM
Apr-26-21 08:58PM
Dec-16-20 09:15AM
Sep-08-20 12:10PM
Protagenic Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. The firm offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Arrow Alexander K.Chief Financial OfficerOct 12 '23Buy0.818,0006,48045,815Oct 13 12:48 PM